These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 31595639)

  • 61. [Synergistic effects of terbinafine and itraconazole antimycotics].
    Korting HC
    Hautarzt; 1999 Jan; 50(1):56-7. PubMed ID: 10068934
    [No Abstract]   [Full Text] [Related]  

  • 62. [The new antifungal preparation Lamisil (terbinafine)].
    Eksp Klin Farmakol; 1993; 56(5):69-79. PubMed ID: 8312820
    [No Abstract]   [Full Text] [Related]  

  • 63. Severe hepatitis during ketoconazole therapy.
    Okumura H; Aramaki T; Satomura K; Iizuka K; Ohta M; Katsuta Y; Akaike M; Terada H; Kusunoki T
    Gastroenterol Jpn; 1983 Apr; 18(2):142-7. PubMed ID: 6303886
    [TBL] [Abstract][Full Text] [Related]  

  • 64. In vitro susceptibility of Microsporum canis and other dermatophyte isolates from veterinary infections during therapy with terbinafine or griseofulvin.
    Hofbauer B; Leitner I; Ryder NS
    Med Mycol; 2002 Apr; 40(2):179-83. PubMed ID: 12058731
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Oral terbinafine in toenail dermatophytosis. A double-blind, placebo-controlled multicenter study with 12 months' follow-up.
    Svejgaard EL; Brandrup F; Kragballe K; Larsen PO; Veien NK; Holst M; Andersen BL; Bro-Jørgensen AV; Dahl JC; Frentz G; Graudal C; Kamp P; Kroman N; Larsen FS; Mikkelsen F; Munkvad JM; Olafsson JH; Rothenborg H; Staberg B; Søndergaard J; Thulin H
    Acta Derm Venereol; 1997 Jan; 77(1):66-9. PubMed ID: 9059684
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Identification and antifungal susceptibility of fungi isolated from dermatomycoses.
    Silva LB; de Oliveira DB; da Silva BV; de Souza RA; da Silva PR; Ferreira-Paim K; Andrade-Silva LE; Silva-Vergara ML; Andrade AA
    J Eur Acad Dermatol Venereol; 2014 May; 28(5):633-40. PubMed ID: 23556501
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Systemic antifungal therapy.
    Moossavi M; Bagheri B; Scher RK
    Dermatol Clin; 2001 Jan; 19(1):35-52. PubMed ID: 11155585
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Loss of taste sensation in terbinafine administration].
    Stricker BH; de Jong PA; Schreuder F; Bijlmer-Iest JC; Herrmann WA; van Ulsen J
    Ned Tijdschr Geneeskd; 1992 Dec; 136(49):2438-40. PubMed ID: 1470246
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Tinea faciei due to Microsporum canis abscess formation.
    Patel G; Mills C
    Clin Exp Dermatol; 2000 Nov; 25(8):608-10. PubMed ID: 11167972
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Ursodeoxycholic acid for terbinafine-induced toxic hepatitis.
    Agca E; Akcay A; Simsek H
    Ann Pharmacother; 2004 Jun; 38(6):1088-9. PubMed ID: 15122001
    [No Abstract]   [Full Text] [Related]  

  • 71. Terbinafine: an oral and topical antifungal agent.
    Shear NH; Villars VV; Marsolais C
    Clin Dermatol; 1991; 9(4):487-95. PubMed ID: 1840406
    [No Abstract]   [Full Text] [Related]  

  • 72. New Topical Therapeutic Options in the Management of Superficial Fungal Infections.
    Zeichner JA
    J Drugs Dermatol; 2015 Oct; 14(10 Suppl):s35-41. PubMed ID: 26461833
    [TBL] [Abstract][Full Text] [Related]  

  • 73. An Implementation and Visualization of the Tree-Based Scan Statistic for Safety Event Monitoring in Longitudinal Electronic Health Data.
    Schachterle SE; Hurley S; Liu Q; Petronis KR; Bate A
    Drug Saf; 2019 Jun; 42(6):727-741. PubMed ID: 30617498
    [TBL] [Abstract][Full Text] [Related]  

  • 74. An evaluation of intermittent therapies used to treat onychomycosis and other dermatomycoses with the oral antifungal agents.
    Gupta AK; Del Rosso JQ
    Int J Dermatol; 2000 Jun; 39(6):401-11. PubMed ID: 10944084
    [No Abstract]   [Full Text] [Related]  

  • 75. Susceptibility of dermatophyte isolates obtained from a large worldwide terbinafine tinea capitis clinical trial.
    Ghannoum MA; Wraith LA; Cai B; Nyirady J; Isham N
    Br J Dermatol; 2008 Sep; 159(3):711-3. PubMed ID: 18510668
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Terbinafine-induced generalized pustular psoriasis in a patient carrying CARD14 mutation.
    Sakai H; Nomura W; Fukushima H; Sugiura K; Iizuka H
    J Dermatol; 2019 Mar; 46(3):e110-e112. PubMed ID: 30144153
    [No Abstract]   [Full Text] [Related]  

  • 77. Update on antifungal therapy with terbinafine.
    Gianni C
    G Ital Dermatol Venereol; 2010 Jun; 145(3):415-24. PubMed ID: 20461049
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effectiveness of terbinafine in cutaneous alternariosis.
    Altomare GF; Capella GL; Boneschi V; Viviani MA
    Br J Dermatol; 2000 Apr; 142(4):840-1. PubMed ID: 10792259
    [No Abstract]   [Full Text] [Related]  

  • 79. Effectiveness of terbinafine in the eradication of Microsporum canis from laboratory cats.
    Castañón-Olivares LR; Manzano-Gayosso P; López-Martínez R; De la Rosa-Velázquez IA; Soto-Reyes-Solís E
    Mycoses; 2001 May; 44(3-4):95-7. PubMed ID: 11413930
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Kerion celsi in an infant treated with oral terbinafine.
    Kobayashi M; Yamamoto O; Suenaga Y; Asahi M
    J Dermatol; 2001 Feb; 28(2):108-9. PubMed ID: 11320705
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.